Risk and Resiliency Factors in the RCMP: A Prospective Investigation
Launched by UNIVERSITY OF REGINA · Sep 1, 2022
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The "Risk and Resiliency Factors in the RCMP: A Prospective Investigation" study is looking into how to better understand and support the mental health of Royal Canadian Mounted Police (RCMP) members. Many RCMP officers face tough situations that can lead to mental health issues like posttraumatic stress injuries (PTSI). This study aims to develop effective ways to assess and treat these challenges, ultimately benefiting all public safety personnel in Canada. It will track new cadets in their training program over five years, comparing traditional training methods to enhanced training that includes skills to help manage stress and trauma.
To participate in this study, you need to be a new cadet starting the RCMP Cadet Training Program. The study will involve regular assessments and surveys to monitor your mental health and how well the training methods work. By joining, you’ll not only help improve your own mental health but also contribute to creating better support systems for all officers in the future. If you have any questions or want to learn more, you can visit the study's website at www.rcmpstudy.ca.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cadets starting the RCMP Cadet Training Program
- Exclusion Criteria:
- • Anyone other than cadets starting the RCMP Cadet Training Program
About University Of Regina
The University of Regina, a prominent Canadian institution known for its commitment to academic excellence and research innovation, serves as a clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a focus on interdisciplinary collaboration, the university leverages its diverse expertise to conduct clinical trials that address pressing health challenges and contribute to evidence-based practices. By fostering partnerships with healthcare professionals and community stakeholders, the University of Regina aims to enhance patient outcomes and promote public health through cutting-edge research and ethical trial management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Regina, Saskatchewan, Canada
Patients applied
Trial Officials
R. Nicholas Carleton, PhD
Principal Investigator
University of Regina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials